Get Sample Pages - Viral Clearance Testing Market Share, Size & Growth Insight

Global Viral Clearance Testing Market Research Report: Forecast (2023-2028)

By Scale of Operation (Discovery Phase, Pre-clinical Phase, Clinical Phase), By Method (Detection , Viral Inactivation, Viral Removal), By Application (Recombinant Proteins, Blood......and Blood Products, Cellular and Gene Therapy Products, Vaccine), By End Users (Biotechnology and Pharmaceutical Companies , Academic / Research Institutes, Contractual Research Organization [CRO]), By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific), By Company (Merck KGaA , Charles River Laboratories, 3P Biopharmaceuticals, Eurofins Scientific, Wuxi Biologics, Kedrion S.p.A, Virusure Gmbh, Texcell SA, Samsung Biologics, Syngene International Limited, Creative Biolab, Creative Biogene, Sartorius AG, Nelson Laboratories LLC, Others) Read more

Healthcare
Mar 2023
Pages 192
Report Format: PDF, Excel, PPT

Market Definition

Viral clearance testing is a process used to demonstrate the ability of a manufacturing process to detect, remove, and inactivate viruses that may be present in biological products, including vaccines, gene therapy vectors, monoclonal antibodies, and recombinant proteins. This testing is performed to ensure the safety of the final product by minimizing the risk of viral contamination & transmission to patients.

Market Insights & Analysis: Global Viral Clearance Testing Market (2023-28)

The Global Viral Clearance Testing market is projected to grow at a CAGR of around 20.10% during the forecast period, i.e., 2023-28. With expanding consumer appetite for biopharmaceutical products, strict regulatory control, and a surge in viral infection rates globally, the market has grown significantly in the past decade, and this trend is expected to continue in the coming year. The prevalence of several viral infections, such as Coronavirus, H1N1, and others, is growing globally, causing companies to manufacture & develop drugs. Due to the government's stringent regulations, this testing is an essential step to ensure the safety & efficacy of biopharmaceutical products, which may be contaminated with viruses, driving demand for this testing & propelling its market expansion.

Furthermore, the development of advanced technologies, like, PCR, next-generation sequencing (NGS), etc., has significantly improved the efficiency & accuracy of this testing. This has led to the inflated adoption of these technologies by biopharmaceutical companies, which increases the resulting efficiency of testing & drives market expansion. Viral Clearance Testing has emerged as one of the key prerequisites for biopharmaceutical products for regulatory approvals to ensure product safety for human consumption.

Report Coverage	Details
Study Period	Historical Data: 2018-21
	Base Year: 2022
	Forecast Period: 2023-28
CAGR (2023-2028)	20.10%
Regions Covered	North America: US, Canada, Mexico
	Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
	Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
	South America: Brazil, Rest of South America
	Middle East & Africa: GCC, South Africa, Egypt, Rest of MEA
Key Companies Profiled	Merck KGaA , Charles River Laboratories, 3P Biopharmaceuticals, Eurofins Scientific, Wuxi Biologics, Kedrion S.p.A, Virusure Gmbh, Texcell SA, Samsung Biologics, Syngene International Limited, Creative Biolab, Creative Biogene, Sartorius AG, Nelson Laboratories LLC, Others
Unit Denominations	USD Million/Billion

For instance, in the manufacturing of the HPV vaccine, Bovine serum is used, including bovine viral diarrhea virus (BVDV) & bovine parvovirus (BPV), which can contaminate the vaccine product. Therefore, to ensure the safety of the HPV vaccine, the regulatory agencies required the manufacturers to perform this testing to demonstrate that the manufacturing process effectively removes or inactivates these potential viral contaminants.

Moreover, virus detection, inactivation, and removal require a skilled workforce & high-tech instruments due to the complexity of testing, which is time-consuming & cost-intensive. Therefore, numerous biopharmaceutical companies such as Takeda Pharmaceutical, Pfizer, Novartis, and others are turning to alternatives such as outsourcing these testing services to FDA-accredited laboratories as the preferred choice to overcome the discrepancy in the test result. Hence, the testing service provider's growth potential in the market has risen.

Global Viral Clearance Testing Market Research Report (2023-2028) - Table of Contents

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Global Viral Clearance Testing Market: Background & Overview
1. Requirement for Viral Clearance Testing
2. Process of Viral Clearance Testing, By Application
3. Viral Contamination in Biologics
Global Viral Clearance Testing Guidelines by Government Organizations
1. The International Council for Harmonisation (ICH)
2. World Health Organisation (WHO)
3. European Medicines Agency (EMEA)
4. Food and Drug Administration (FDA)
Global Viral Clearance Testing Market Patent Analysis
Global Viral Clearance Testing Market Technology Landscape
1. List of Technology
2. Technology Provider
3. Method Used
4. Regional Services
5. Year of Launch
6. Partnership & Collaborations
Global Viral Clearance Testing Market Trends & Developments
Global Viral Clearance Testing Market Dynamics
1. Growth Drivers
2. Challenges
Global Viral Clearance Testing Market Hotspot & Opportunities
Global Viral Clearance Testing Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Scale of Operation
    1. Discovery Phase
    2. Pre-clinical Phase
    3. Clinical Phase
  2. By Method
    1. Detection
    2. Viral Inactivation
    3. Viral Removal
  3. By Application
    1. Recombinant Proteins
    2. Blood and Blood Products
    3. Cellular and Gene Therapy Products
    4. Vaccine
  4. By End Users
    1. Biotechnology and Pharmaceutical Companies
    2. Academic / Research Institutes
    3. Contractual Research Organization (CRO)
  5. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
  6. By Company
    1. Competition Characteristics
    2. Revenue Shares & Analysis
North America Viral Clearance Testing Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Scale of Operation
  2. By Method
  3. By Application
  4. By End User
  5. By Country
    1. The US
    2. Canada
    3. Mexico
3. The United States Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
4. Canada Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
5. Mexico Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
South America Viral Clearance Testing Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Scale of Operation
  2. By Method
  3. By Application
  4. By End User
  5. By Country
    1. Brazil
    2. Rest of South America
3. Brazil Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
Europe Viral Clearance Testing Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Scale of Operation
  2. By Method
  3. By Application
  4. By End User
  5. By Country
    1. Germany
    2. The UK
    3. France
    4. Italy
    5. Spain
    6. Rest of Europe
3. Germany Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
4. The UK Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
5. France Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
6. Italy Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
7. Spain Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
Middle East & Africa Viral Clearance Testing Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Scale of Operation
  2. By Method
  3. By Application
  4. By End User
  5. By Country
    1. GCC
    2. South Africa
    3. Rest of MEA
3. GCC Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
4. South Africa Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
Asia-Pacific Viral Clearance Testing Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Scale of Operation
  2. By Method
  3. By Application
  4. By End User
  5. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Australia
    6. Rest of Asia-Pacific
3. China Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
4. India Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
5. Japan Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
6. South Korea Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
7. Australia Viral Clearance Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Scale of Operation
    2. By Method
Global Viral Clearance Testing Market Key Strategic Imperatives for Success & Growth
Competition Outlook
1. Competition Matrix
  1. Product Portfolio
  2. Target Markets
  3. Research & Development
  4. Strategic Alliances
  5. Strategic Initiatives
2. Company Profiles (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. Merck KGaA
  2. Charles River Laboratories
  3. 3P Biopharmaceuticals
  4. Eurofins Scientific
  5. Wuxi Biologics
  6. Kedrion S.p.A
  7. Virusure Gmbh
  8. Texcell SA
  9. Samsung Biologics
  10. Syngene International Limited
  11. Creative Biolab
  12. Creative Biogene
  13. Sartorius AG
  14. Nelson Laboratories LLC
  15. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Name *

Email ID *

Country *